-
SG Cell Line 96-well Nucleofector® KitCatalog #: V4SC-3096
For medium-throughput transfection of cell lines, e.g. Ba/F3, Raji or THP-1, when working with the 4D-Nucleofector® 96-well Unit
Sales unit: kit -
Cell Line Optimization 384-well Nucleofector™ KitCatalog #: V5SC-9001For high-throughput optimization of transfection conditions for cell lines lacking an Optimized Protocol for the 384-well HT NucleofectorTM SystemSales unit: items
-
LGM-3TM Lymphocyte Growth Medium-3Catalog #: CC-3211
Serum-free growth medium required for growth of human lymphocytes and dendritic cells, 500 mL
Sales unit: each -
ProCHO® 4 Protein-free CHO Medium, 1LCatalog #: BP04-919Q
ProCHO® 4 Protein-free CHO Medium with 0.1% Pluronic® F-68, without L-Glutamin, phenol red, hypoxanthine or thymidine, 1 L
Sales unit: Bottle -
FGM™-2 Fibroblast Growth Medium-2 SingleQuots™ Supplements and Growth FactorsCatalog #: CC-4126
FGMTM-2 Fibroblast SingleQuotsTM Kit
Sales unit: each -
KBM™ Keratinocyte Basal Medium, Calcium FreeCatalog #: CC-3104
KBMTM Keratinocyte Basal Medium, Calcium Free, 500 mL
Sales unit: each -
ProCHO® 5 Protein-free CHO Medium NAO, Powder kit w/o PR 10 LCatalog #: BE15-766D
ProCHO® 5, protein free CHO medium, with HEPES and 0.1% Pluronic® F-68, without L-Glutamine, phenol red, hypoxanthine or thymidine, 10 L powder kit(NAO)
Sales unit: kit -
ProCHO® 5 Protein-free CHO Medium NAO, Basal Powder, w/o PR 500 LCatalog #: WPW-045L
ProCHO® 5, protein free CHO medium, basal powder, 500 L (NAO)
Sales unit: pail -
ProCHO® 5 Protein-free CHO Medium NAO, Powder kit w/o PR 50 LCatalog #: BE15-766F
ProCHO® 5, protein free CHO medium, with HEPES and 0.1% Pluronic® F-68, without L-Glutamine, phenol red, hypoxanthine or thymidine, 50 L powder kit (NAO)
Sales unit: kit -
ProCHO® 5 Protein-free CHO Medium NAO, Basal Powder, w/o PR 50 LCatalog #: WPW-045F
ProCHO® 5, protein free CHO medium, basal powder, 50 L (NAO)
Sales unit: pail
-
Inducible Cas9 T Cells: An Innovative Platform for Allogeneic CAR-T Cell GenerationPoster on inducible Cas9 T Cells
-
Synthego_Lonza_Protocol_Genome Editing of Resting T cellsTechnical Protocol on Genome Editing of Resting T cells for associated White Paper "Genome Editing of Resting T cells"
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
-
PBMC Based T Cell Proliferation AssayProtocol instructions
-
Instructions for Use – TheraPEAK® T-VIVO® Cell Culture Medium for Gamma Delta (γδ) T CellsInstructions for how to culture gamma delta (γδ) T Cells using TheraPEAK® T-VIVO® Cell Culture Medium
-
Instructions for Use - Dendritic Cell (DC) and T Cell Assay from Matched PBMCsProtocol for DC and T Cell Assay from Matched PBMCs
-
Case Study – Improving the Expansion of Patients' T CellsIn this serum-free media case study, learn how selection of memory T cells can aid in streamlining CAR-T therapies.
-
Synthego-Lonza Genome Editing of Resting T cellsCase Study on Genome Editing of Resting T cells
-
cGMP Kit T Optimization Protocol - Nucleofector™ 1/2 Device SeriescGMP Cell Line Nucleofector Kit T
-
CAR-T Cells – Latest Advances and Outstanding Challenges